Will Ashworth

Will Ashworth

InvestorPlace Contributor

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

7 Hot Sectors to Ride for the Rest of 2021

By Will Ashworth, InvestorPlace Contributor

As we're early in 2021, investors are looking for hot sectors to ride for the rest of the year and into 2022. Here are seven to choose from.

What’s Better? 1 Share of GameStop or 13 of Hims & Hers Health?

By Will Ashworth, InvestorPlace Contributor

You can buy one share of GameStop or 13 shares of Hims & Hers Health. The smart money is buying HIMS stock at current prices.   

7 International Stocks for Worldwide Profits 

By Will Ashworth, InvestorPlace Contributor

For those investors looking farther afield for their equity investments, here are seven international stocks to buy for worldwide profits. 

Buy Jumia Technologies as Big Players Start Jumping In

By Will Ashworth, InvestorPlace Contributor

The company’s top owners can tell you about a stock’s potential. When it comes to Jumia Technologies and JMIA stock, there’s a lot to like. 

Do We Know Enough About Napo Pharma’s SPAC To Invest In Jaguar Health?

By Will Ashworth, InvestorPlace Contributor

Jaguar Health might merge part of its Napo Pharmaceuticals unit with a SPAC. What’s this mean for JAGX stock over the long haul? 

Load More